$4.59
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. With its vertically integrated approach, the Company owns and operates two purpose built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada. Additionally, it holds a Dealer’s Licence under Canada’s Narcotic Control Regulations, allowing the Company to possess, produce, assemble, sell and deliver psilocybin and other psychedelic substances within the regulated framework set forth by Health Canada.
Country

CA

CEO

Mr. Dane Stevens

IPO date

2021

Employees

9

ISIN

CA68405H1001

Key stats

Open

$4.79

Volume

69.53K

Market cap

$27.74M

Prev. close

$4.88

Impl / hst vl

-

Open interest

$0.00

$4.59

Day’s Range

$5.00

$4.00

52W Range

$6.20

Valuation

11
Valuation score
Strongly Overvalued
P/E
-
P/S
-
P/B
7.85
Current ratio
0.12
Debt / Equity
1.21
ROE
-
Gross margin
-
Income growth
-
FCF growth
-55.86

Analysts estimates

Avg. price target
$10.76
The top 3 analysts forecasts that 12-month price may increase by 134.33%, with a low of $10.65 and a high of $11.07
$10.65
Low
$10.76
Avg
$11.07
High
Current price

Earnings

Q4 ‘25 revenue
$0.00
Q4 ‘25 net income
-$1.09M
Revenue
Net income
Previous EPS
-
Estimate EPS
-$0.26
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply